Tapewire

Nasdaq · USD

MDGL

MADRIGAL PHARMACEUTICALS, INC.

Export transactions ↓
Tapewire entity
3441
SEC CIK
0001157601
Parsed reports
271

Last 12 months

Inside the activity.

0 purchase rows · 202 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025036
Dec 2025034
Jan 2026066
Feb 202600
Mar 2026017
Apr 202600
May 2026013
Jun 202601
Jul 2026010
Aug 202601
Sep 2026024
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 23, 2022 Filed Dec 29, 2022 01:00 UTC
Sukhija RemyChief Commercial Officer
Exercise / conversionCommon Stock 30,000 $60.26 $1,807,800.00
Disclosure

SEC source: 0000899243-22-039463 · doc4.xml · nonDerivative · entry 1

Sukhija Remy · CIK 0001806949 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: All transactions reported herein were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. After giving effect to these transactions, the reporting person's Rule 10b5-1 trading plan has been concluded and no more trading will be conducted thereunder.

Read SEC document
August 10, 2022 Filed Aug 12, 2022 20:30 UTC
Lynch Brian JosephSVP and General Counsel
GrantStock Option (Right to Buy) · Derivative 25,000 $0.00 Strike: $73.75 $0.00
Disclosure

SEC source: 0000899243-22-028491 · doc4.xml · derivative · entry 1

Lynch Brian Joseph · CIK 0001776196 · SVP and General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2032-08-10

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (08/10/2023) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 06:30 UTC GrantStock Option (Right to Buy) · Derivative 9,470 $0.00 Strike: $65.06 $0.00
Disclosure

SEC source: 0000899243-22-023232 · doc4.xml · derivative · entry 1

CRAVES FRED B · CIK 0001014095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,470

Underlying: Common Stock · 9,470 shares

Expires 2025-06-16

F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 10:30 UTC
BATE KENNETHDirector
GrantStock Option (Right to Buy) · Derivative 9,470 $0.00 Strike: $65.06 $0.00
Disclosure

SEC source: 0000899243-22-023234 · doc4.xml · derivative · entry 1

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,470

Underlying: Common Stock · 9,470 shares

Expires 2025-06-16

F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 10:30 UTC GrantStock Option (Right to buy) · Derivative 9,470 $0.00 Strike: $65.06 $0.00
Disclosure

SEC source: 0000899243-22-023233 · doc4.xml · derivative · entry 1

MILLIGAN DAVID V · CIK 0001222252 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,470

Underlying: Common Stock · 9,470 shares

Expires 2025-06-16

F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 10:30 UTC GrantStock Option (Right to buy) · Derivative 9,470 $0.00 Strike: $65.06 $0.00
Disclosure

SEC source: 0000899243-22-023231 · doc4.xml · derivative · entry 1

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,470

Underlying: Common Stock · 9,470 shares

Expires 2025-06-16

F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 10:30 UTC
Daly James MDirector
GrantStock Option (Right to Buy) · Derivative 9,470 $0.00 Strike: $65.06 $0.00
Disclosure

SEC source: 0000899243-22-023230 · doc4.xml · derivative · entry 1

Daly James M · CIK 0001560782 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,470

Underlying: Common Stock · 9,470 shares

Expires 2025-06-16

F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.

Read SEC document
June 16, 2022 Filed Jun 21, 2022 10:30 UTC GrantStock Option (Right to Buy) · Derivative 9,470 $0.00 Strike: $65.06 $0.00
Disclosure

SEC source: 0000899243-22-023229 · doc4.xml · derivative · entry 1

Gollust Keith R · CIK 0001325712 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,470

Underlying: Common Stock · 9,470 shares

Expires 2025-06-16

F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.

Read SEC document
February 24, 2022 Filed Feb 25, 2022 01:17 UTC
Waltermire Robert E.Senior VP, Chief Pharma Dev.
GrantCall Option · Derivative 12,250 $0.00 Strike: $87.09 $0.00
Disclosure

SEC source: 0000899243-22-007774 · doc4.xml · derivative · entry 1

Waltermire Robert E. · CIK 0001876996 · Senior VP, Chief Pharma Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,250

Underlying: Common Stock · 12,250 shares

Expires 2022-02-24

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/24/2023) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document
February 22, 2022 Filed Feb 25, 2022 01:40 UTC
Howarth Alex G.Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $87.09 $0.00
Disclosure

SEC source: 0000899243-22-007779 · doc4.xml · derivative · entry 1

Howarth Alex G. · CIK 0001795798 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2032-02-22

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2023) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document
February 22, 2022 Filed Feb 25, 2022 01:18 UTC
Lynch Brian JosephSVP and General Councel
GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $87.09 $0.00
Disclosure

SEC source: 0000899243-22-007776 · doc4.xml · derivative · entry 1

Lynch Brian Joseph · CIK 0001776196 · SVP and General Councel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2032-02-22

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2023) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document
February 22, 2022 Filed Feb 25, 2022 01:18 UTC
Sukhija RemyChief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $87.09 $0.00
Disclosure

SEC source: 0000899243-22-007775 · doc4.xml · derivative · entry 1

Sukhija Remy · CIK 0001806949 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2032-02-22

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2023) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document
February 22, 2022 Filed Feb 25, 2022 01:12 UTC
Taub RebeccaDirector · See Remarks
GrantStock Option (Right to Buy) · Derivative 61,500 $0.00 Strike: $87.09 $0.00
Disclosure

SEC source: 0000899243-22-007769 · doc4.xml · derivative · entry 1

Taub Rebecca · CIK 0001423898 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,500

Underlying: Common Stock · 61,500 shares

Expires 2032-02-22

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2023) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document
February 22, 2022 Filed Feb 25, 2022 01:10 UTC
FRIEDMAN PAUL ADirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 70,000 $0.00 Strike: $87.09 $0.00
Disclosure

SEC source: 0000899243-22-007766 · doc4.xml · derivative · entry 1

FRIEDMAN PAUL A · CIK 0001236927 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Underlying: Common Stock · 70,000 shares

Expires 2032-02-22

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2023) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document
December 31, 2021 Filed Feb 2, 2022 16:05 UTC
CRAVES FRED BDirector · 10% owner
GiftCommon Stock 3,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-004133 · doc5.xml · nonDerivative · entry 1

CRAVES FRED B · CIK 0001014095 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 361,358

F1 · kind: Represents a bona fide gift of 3,000 shares of common stock from Dr. Craves to the Fred Craves Family Foundation.

Read SEC document
December 03, 2021 Filed Dec 7, 2021 16:30 UTC
CRAVES FRED BDirector · 10% owner
OtherCommon Stock 24,172 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-047115 · doc4.xml · nonDerivative · entry 3

CRAVES FRED B · CIK 0001014095 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,261

F7 · kind: Represents transfers, without the payment of any consideration, to their partners and employees.

F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

F4 · ownership.nature: These securities are held by BCC. Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC.

Read SEC document
December 03, 2021 Filed Dec 7, 2021 16:30 UTC
CRAVES FRED BDirector · 10% owner
OtherCommon Stock 49,730 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-047115 · doc4.xml · nonDerivative · entry 2

CRAVES FRED B · CIK 0001014095 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

F7 · kind: Represents transfers, without the payment of any consideration, to their partners and employees.

F7 · acquired: Represents transfers, without the payment of any consideration, to their partners and employees.

F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

F3 · ownership.nature: These securities were held by Co-Investment IV. Dr. Craves disclaims beneficial ownership of these securities previously held by Co-Investment IV, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC.

Read SEC document
December 03, 2021 Filed Dec 7, 2021 16:30 UTC
CRAVES FRED BDirector · 10% owner
OtherCommon Stock 750,270 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-047115 · doc4.xml · nonDerivative · entry 1

CRAVES FRED B · CIK 0001014095 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,510,521

F7 · kind: Represents transfers, without the payment of any consideration, to their partners and employees.

F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

F2 · ownership.nature: These securities are held by Fund IV. Dr. Craves disclaims beneficial ownership of these securities held by Fund IV, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC.

Read SEC document
December 03, 2021 Filed Dec 7, 2021 21:30 UTC OtherCommon Stock 24,172 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-047117 · doc4.xml · nonDerivative · entry 3

BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner

Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner

Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner

BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,261

F4 · kind: Represents transfers, without the payment of any consideration, to their partners and employees.

F1 · ownership.direct: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

Read SEC document
December 03, 2021 Filed Dec 7, 2021 21:30 UTC OtherCommon Stock 49,730 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-047117 · doc4.xml · nonDerivative · entry 2

BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner

Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner

Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner

BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 0

F4 · kind: Represents transfers, without the payment of any consideration, to their partners and employees.

F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

F3 · ownership.nature: The securities were held by Co-Investment IV.

Read SEC document
December 03, 2021 Filed Dec 7, 2021 21:30 UTC OtherCommon Stock 750,270 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-047117 · doc4.xml · nonDerivative · entry 1

BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner

Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner

Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner

BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 1,510,521

F4 · kind: Represents transfers, without the payment of any consideration, to their partners and employees.

F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

F2 · ownership.nature: The securities are held by Fund IV.

Read SEC document
November 01, 2021 Filed Nov 3, 2021 20:26 UTC
Howarth Alex G.Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $81.95 $0.00
Disclosure

SEC source: 0000899243-21-042719 · doc4.xml · derivative · entry 1

Howarth Alex G. · CIK 0001795798 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,000

Underlying: Common Stock · 5,000 shares

Expires 2031-11-01

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (11/1/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date. This option was granted under our 2015 stock plan at a regularly scheduled meeting of the Compensation Committee of our Board of Directors on November 1, 2021.

Read SEC document
August 02, 2021 Filed Aug 5, 2021 01:46 UTC
Waltermire Robert E.Senior VP, Chief Pharma Dev.
GrantCall Option · Derivative 35,000 $0.00 Strike: $87.92 $0.00
Disclosure

SEC source: 0000899243-21-031720 · doc4.xml · derivative · entry 1

Waltermire Robert E. · CIK 0001876996 · Senior VP, Chief Pharma Dev.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2031-08-02

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (08/02/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document
June 17, 2021 Filed Jun 21, 2021 08:03 UTC GrantStock Option (Right to Buy) · Derivative 12,489 $0.00 Strike: $105.08 $0.00
Disclosure

SEC source: 0000899243-21-024668 · doc4.xml · derivative · entry 1

CRAVES FRED B · CIK 0001014095 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,489

Underlying: Common Stock · 12,489 shares

Expires 2024-06-17

F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.

Read SEC document
June 17, 2021 Filed Jun 21, 2021 12:03 UTC
Daly James MDirector
GrantStock Option (Right to Buy) · Derivative 12,489 $0.00 Strike: $105.08 $0.00
Disclosure

SEC source: 0000899243-21-024669 · doc4.xml · derivative · entry 1

Daly James M · CIK 0001560782 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,489

Underlying: Common Stock · 12,489 shares

Expires 2024-06-17

F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.

Read SEC document
June 17, 2021 Filed Jun 21, 2021 12:02 UTC GrantStock Option (Right to buy) · Derivative 12,489 $0.00 Strike: $105.08 $0.00
Disclosure

SEC source: 0000899243-21-024666 · doc4.xml · derivative · entry 1

MILLIGAN DAVID V · CIK 0001222252 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,489

Underlying: Common Stock · 12,489 shares

Expires 2024-06-17

F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.

Read SEC document
June 17, 2021 Filed Jun 21, 2021 12:02 UTC
BATE KENNETHDirector
GrantStock Option (Right to Buy) · Derivative 12,489 $0.00 Strike: $105.08 $0.00
Disclosure

SEC source: 0000899243-21-024665 · doc4.xml · derivative · entry 1

BATE KENNETH · CIK 0001210238 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,489

Underlying: Common Stock · 12,489 shares

Expires 2024-06-17

F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.

Read SEC document
June 17, 2021 Filed Jun 21, 2021 12:00 UTC GrantStock Option (Right to Buy) · Derivative 12,489 $0.00 Strike: $105.08 $0.00
Disclosure

SEC source: 0000899243-21-024663 · doc4.xml · derivative · entry 1

Gollust Keith R · CIK 0001325712 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,489

Underlying: Common Stock · 12,489 shares

Expires 2024-06-17

F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.

Read SEC document
June 17, 2021 Filed Jun 21, 2021 12:02 UTC GrantStock Option (Right to buy) · Derivative 12,489 $0.00 Strike: $105.08 $0.00
Disclosure

SEC source: 0000899243-21-024664 · doc4.xml · derivative · entry 1

Levy Richard S · CIK 0001454983 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,489

Underlying: Common Stock · 12,489 shares

Expires 2024-06-17

F1 · derivative.exercise_date: The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date.

Read SEC document
May 17, 2021 Filed May 19, 2021 19:40 UTC
Howarth Alex G.Chief Financial Officer
GrantStock Option (Right to Buy) · Derivative 65,000 $0.00 Strike: $134.00 $0.00
Disclosure

SEC source: 0000899243-21-019909 · doc4.xml · derivative · entry 1

Howarth Alex G. · CIK 0001795798 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 65,000

Underlying: Common Stock · 65,000 shares

Expires 2031-05-17

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (05/17/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document
February 22, 2021 Filed Feb 23, 2021 18:35 UTC
FRIEDMAN PAUL ADirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 50,000 $0.00 Strike: $119.49 $0.00
Disclosure

SEC source: 0000899243-21-007765 · doc4.xml · derivative · entry 1

FRIEDMAN PAUL A · CIK 0001236927 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2031-02-22

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document
February 22, 2021 Filed Feb 23, 2021 18:32 UTC
Schneebaum Marc RChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 32,000 $0.00 Strike: $119.49 $0.00
Disclosure

SEC source: 0000899243-21-007763 · doc4.xml · derivative · entry 1

Schneebaum Marc R · CIK 0001396871 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,000

Underlying: Common Stock · 32,000 shares

Expires 2031-02-22

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document
February 22, 2021 Filed Feb 23, 2021 18:31 UTC
Sukhija RemyChief Commercial Officer
GrantStock Option (Right to Buy) · Derivative 24,000 $0.00 Strike: $119.49 $0.00
Disclosure

SEC source: 0000899243-21-007761 · doc4.xml · derivative · entry 1

Sukhija Remy · CIK 0001806949 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,000

Underlying: Common Stock · 24,000 shares

Expires 2031-02-22

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document
February 22, 2021 Filed Feb 23, 2021 18:29 UTC
Lynch Brian JosephSVP and General Councel
GrantStock Option (Right to Buy) · Derivative 32,000 $0.00 Strike: $119.49 $0.00
Disclosure

SEC source: 0000899243-21-007759 · doc4.xml · derivative · entry 1

Lynch Brian Joseph · CIK 0001776196 · SVP and General Councel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,000

Underlying: Common Stock · 32,000 shares

Expires 2031-02-22

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document
February 22, 2021 Filed Feb 23, 2021 18:28 UTC
Taub RebeccaDirector · See Remarks
GrantStock Option (Right to Buy) · Derivative 44,000 $0.00 Strike: $119.49 $0.00
Disclosure

SEC source: 0000899243-21-007758 · doc4.xml · derivative · entry 1

Taub Rebecca · CIK 0001423898 · Director · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,000

Underlying: Common Stock · 44,000 shares

Expires 2031-02-22

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (02/22/2022) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document
December 30, 2020 Filed Feb 11, 2021 15:50 UTC
CRAVES FRED BDirector · 10% owner
GiftCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-21-005912 · doc5.xml · nonDerivative · entry 2

CRAVES FRED B · CIK 0001014095 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 317,579

F3 · kind: Represents a bona fide gift of 15,000 shares of common stock from Dr. Craves to the Fred Craves Family Foundation.

F4 · balance_after: Reflects a transfer of 43,537 shares of common stock from BCC to Dr. Craves and a transfer of 80,974 shares of common stock from Dr. Craves to a former spouse pursuant to a court approved divorce settlement agreement.

F3 · ownership.direct: Represents a bona fide gift of 15,000 shares of common stock from Dr. Craves to the Fred Craves Family Foundation.

F4 · ownership.direct: Reflects a transfer of 43,537 shares of common stock from BCC to Dr. Craves and a transfer of 80,974 shares of common stock from Dr. Craves to a former spouse pursuant to a court approved divorce settlement agreement.

Read SEC document
December 01, 2020 Filed Dec 2, 2020 02:36 UTC OtherCommon Stock 43,537 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-032411 · doc4.xml · nonDerivative · entry 1

BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner

Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner

Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner

BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 2,310,521

F1 · kind: Represents a transfer, without the payment of any consideration, to an affiliate.

F1 · ownership.nature: Represents a transfer, without the payment of any consideration, to an affiliate.

F2 · ownership.nature: Includes 2,260,791 shares of common stock held by Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and 49,730 shares of common stock held by Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV"). Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Fund IV and Co-Investment IV are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

Read SEC document
September 04, 2020 Filed Sep 4, 2020 21:06 UTC
CRAVES FRED BDirector · 10% owner
OtherCommon Stock 45,460 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-024410 · doc4.xml · nonDerivative · entry 3

CRAVES FRED B · CIK 0001014095 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 43,537

F6 · kind: Represents transfers, without the payment of any consideration, to their partners and employees.

F6 · shares: Represents transfers, without the payment of any consideration, to their partners and employees.

F6 · price: Represents transfers, without the payment of any consideration, to their partners and employees.

F6 · acquired: Represents transfers, without the payment of any consideration, to their partners and employees.

F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

F4 · ownership.nature: These securities are held by BCC. Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC.

Read SEC document
September 04, 2020 Filed Sep 4, 2020 21:06 UTC
CRAVES FRED BDirector · 10% owner
OtherCommon Stock 31,650 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-024410 · doc4.xml · nonDerivative · entry 2

CRAVES FRED B · CIK 0001014095 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 49,730

F6 · kind: Represents transfers, without the payment of any consideration, to their partners and employees.

F6 · shares: Represents transfers, without the payment of any consideration, to their partners and employees.

F6 · price: Represents transfers, without the payment of any consideration, to their partners and employees.

F6 · acquired: Represents transfers, without the payment of any consideration, to their partners and employees.

F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

F3 · ownership.nature: These securities are held by Co-Investment IV. Dr. Craves disclaims beneficial ownership of these securities held by Co-Investment IV, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC.

Read SEC document
September 04, 2020 Filed Sep 4, 2020 21:06 UTC
CRAVES FRED BDirector · 10% owner
OtherCommon Stock 1,468,350 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-024410 · doc4.xml · nonDerivative · entry 1

CRAVES FRED B · CIK 0001014095 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 2,260,791

F6 · kind: Represents transfers, without the payment of any consideration, to their partners and employees.

F6 · shares: Represents transfers, without the payment of any consideration, to their partners and employees.

F6 · price: Represents transfers, without the payment of any consideration, to their partners and employees.

F6 · acquired: Represents transfers, without the payment of any consideration, to their partners and employees.

F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

F2 · ownership.nature: These securities are held by Fund IV. Dr. Craves disclaims beneficial ownership of these securities held by Fund IV, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC.

Read SEC document
September 04, 2020 Filed Sep 5, 2020 01:09 UTC OtherCommon Stock 45,460 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-024411 · doc4.xml · nonDerivative · entry 3

BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner

Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner

Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner

BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,537

F4 · kind: Represents transfers, without the payment of any consideration, to their partners and employees.

F4 · shares: Represents transfers, without the payment of any consideration, to their partners and employees.

F4 · price: Represents transfers, without the payment of any consideration, to their partners and employees.

F4 · acquired: Represents transfers, without the payment of any consideration, to their partners and employees.

F1 · ownership.direct: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

Read SEC document
September 04, 2020 Filed Sep 5, 2020 01:09 UTC OtherCommon Stock 31,650 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-024411 · doc4.xml · nonDerivative · entry 2

BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner

Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner

Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner

BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 49,730

F4 · kind: Represents transfers, without the payment of any consideration, to their partners and employees.

F4 · shares: Represents transfers, without the payment of any consideration, to their partners and employees.

F4 · price: Represents transfers, without the payment of any consideration, to their partners and employees.

F4 · acquired: Represents transfers, without the payment of any consideration, to their partners and employees.

F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

F3 · ownership.nature: The securities are held by Co-Investment IV.

Read SEC document
September 04, 2020 Filed Sep 5, 2020 01:09 UTC OtherCommon Stock 1,468,350 $0.00 $0.00
Disclosure

SEC source: 0000899243-20-024411 · doc4.xml · nonDerivative · entry 1

BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner

Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner

Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner

BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 2,260,791

F4 · kind: Represents transfers, without the payment of any consideration, to their partners and employees.

F4 · shares: Represents transfers, without the payment of any consideration, to their partners and employees.

F4 · price: Represents transfers, without the payment of any consideration, to their partners and employees.

F4 · acquired: Represents transfers, without the payment of any consideration, to their partners and employees.

F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

F2 · ownership.nature: The securities are held by Fund IV.

Read SEC document
August 19, 2020 Filed Aug 19, 2020 19:40 UTC
CRAVES FRED BDirector · 10% owner
SaleCommon Stock 7,303 $107.64 $786,094.92
Disclosure

SEC source: 0000899243-20-022971 · doc4.xml · nonDerivative · entry 3

CRAVES FRED B · CIK 0001014095 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 42,875

F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

F2 · ownership.nature: These securities are held by BCC. Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC.

Read SEC document
August 19, 2020 Filed Aug 19, 2020 23:40 UTC SaleCommon Stock 7,303 $107.64 $786,094.92
Disclosure

SEC source: 0000899243-20-022972 · doc4.xml · nonDerivative · entry 3

BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner

Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner

Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner

BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,875

F1 · ownership.direct: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

Read SEC document
August 18, 2020 Filed Aug 19, 2020 19:40 UTC
CRAVES FRED BDirector · 10% owner
SaleCommon Stock 10,197 $110.03 $1,121,975.91
Disclosure

SEC source: 0000899243-20-022971 · doc4.xml · nonDerivative · entry 2

CRAVES FRED B · CIK 0001014095 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 50,178

F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

F2 · ownership.nature: These securities are held by BCC. Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC.

Read SEC document
August 18, 2020 Filed Aug 19, 2020 23:40 UTC SaleCommon Stock 10,197 $110.03 $1,121,975.91
Disclosure

SEC source: 0000899243-20-022972 · doc4.xml · nonDerivative · entry 2

BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner

Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner

Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner

BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,178

F1 · ownership.direct: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

Read SEC document
August 17, 2020 Filed Aug 19, 2020 19:40 UTC
CRAVES FRED BDirector · 10% owner
SaleCommon Stock 12,500 $110.73 $1,384,125.00
Disclosure

SEC source: 0000899243-20-022971 · doc4.xml · nonDerivative · entry 1

CRAVES FRED B · CIK 0001014095 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Footnotes

Disclosed balance after: 60,375

F1 · ownership.nature: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

F2 · ownership.nature: These securities are held by BCC. Dr. Craves disclaims beneficial ownership of these securities held by BCC, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such shares, except to the extent of his pecuniary interest, if any, in the securities by virtue of the limited liability company interests he owns in BCC.

Read SEC document
August 17, 2020 Filed Aug 19, 2020 23:40 UTC SaleCommon Stock 12,500 $110.73 $1,384,125.00
Disclosure

SEC source: 0000899243-20-022972 · doc4.xml · nonDerivative · entry 1

BAY CITY CAPITAL LLC · CIK 0001288452 · 10% owner

Bay City Capital Management IV LLC · CIK 0001359070 · 10% owner

Bay City Capital Fund IV, L.P. · CIK 0001360243 · 10% owner

BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP · CIK 0001333817 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,375

F1 · ownership.direct: Bay City Capital LLC, a Delaware limited liability company ("BCC"), Bay City Capital Management IV LLC, a Delaware limited liability company ("Management IV"), Bay City Capital Fund IV, L.P., a Delaware limited partnership ("Fund IV"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership ("Co-Investment IV") are deemed to be a "group" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV.

Read SEC document
August 06, 2020 Filed Aug 10, 2020 23:07 UTC GrantStock Option (Right to Buy) · Derivative 20,000 $0.00 Strike: $103.10 $0.00
Disclosure

SEC source: 0000899243-20-021949 · doc4.xml · derivative · entry 1

Lynch Brian Joseph · CIK 0001776196 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

Underlying: Common Stock · 20,000 shares

Expires 2030-08-06

F1 · derivative.exercise_date: The option vests as to 25% of the shares on the first anniversary of the date of grant (August 6, 2021) and, thereafter, 6.25% of the shares shall vest on the last day of each successive three month period, provided the Reporting Person continues in service with the Issuer on each such date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.